Benefits of DOT are that it has been shown to:

  • Decrease both the acquisition and transmission of drug-resistant tuberculosis, and
  • Increase treatment success in HIV-positive patients

 

 

Further Reading

Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. https://www.ncbi.nlm.nih.gov/pubmed/27516382

print